FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreMonica Bertagnolli, MD, the new director of the National Institutes of Health (NIH), and Robert Califf, MD, commissioner of the U.S. Food and Drug Administration, this week focused on clinical trials and efficiencies, and data management during presentations at the Friends of Cancer Research annual meeting in Washington, DC.
Dr. Bertagnolli emphasized the importance of designing evidence to bring the doctor and patient together in decision-making events and seeing the clinical care environment as a learning laboratory. She also highlighted the federal government’s need to increase enrollment in clinical trials to expand opportunities for patient access and diversity. The topic of clinical trials is of interest to the American College of Radiology® (ACR®), as ACR has been fortunate to partner with NIH, specifically in the National Cancer Institute’s clinical trials network.
A recording of the meeting is available online.
For more information, contact Katie Grady, ACR Government Affairs Director.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more